Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

NCT06905210 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris
Acne Vulgaris on the Face

Interventions

DRUG: Placebo of the experimental drug
DRUG: Experimental drug

Sponsor

Eurofarma Laboratorios S.A.